Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
Reporter Name | Egbuonu-Davis Lisa |
Relationship | Director |
Type | Sell |
Amount | $32,239 |
SEC Filing | Form 4 |
Phreesia Director, Lisa Egbuonu-Davis, sold 1,400 shares of common stock on September 12, 2024, at a price of $23.028 per share, totaling $32,239. Following the transaction, Egbuonu-Davis directly owns 18,139 shares of Phreesia.
SEC Filing: Phreesia, Inc. [ PHR ] - Form 4 - Sep. 13, 2024
Reporter Name | Relationship | Type | Amount | SEC Filing |
---|---|---|---|---|
Hoffman Allison C | General Counsel & Secretary | Sell | $109,363 | Form 4 |
Vanduyn Amy Beth | SVP, Human Resources | Sell | $17,135 | Form 4 |
Roberts Evan | Chief Operating Officer | Sell | $73,191 | Form 4 |
Linetsky David | SVP, Life Sciences | Sell | $42,106 | Form 4 |
Several executives at Phreesia have recently engaged in significant stock transactions, as reported in SEC Form 4 filings.
Allison C Hoffman, General Counsel & Secretary, sold a total of 4,694 shares on September 10 and 11, 2024, for a total amount of $109,363. The sales were conducted at a weighted average price of $23.2502 on September 10, with a range of $22.94 to $23.17, and at $23.36 per share on September 11. Following these transactions, Hoffman directly owns 121,003 shares of Phreesia.
Amy Beth VanDuyn, SVP of Human Resources, sold 737 shares on September 10, 2024, at a weighted average price of $23.2502 per share, totaling $17,135. This sale was part of a mandatory sell-to-cover policy for tax withholding on RSU settlement, leaving VanDuyn with 119,541 direct shares.
Evan Roberts, Chief Operating Officer, sold 3,148 shares on September 10, 2024, for a total of $73,191, at a weighted average price of $23.2502 per share. This transaction was also part of a mandatory sell-to-cover policy for tax obligations, after which Roberts directly owns 755,719 shares.
David Linetsky, SVP of Life Sciences, sold 1,811 shares on September 10, 2024, for a total of $42,106, at a weighted average price of $23.2502 per share. Following these sales, Linetsky directly owns 203,318 shares and indirectly owns 9,092 shares through his spouse. These transactions were similarly aimed at covering tax obligations on RSU settlements.
Shares of Teladoc Health, Inc. TDOC have dropped 31.2% over the past three months to close at $7.19 on Monday, near its 52-week low of $6.76. Having underperformed its industry and the S&P 500, the company’s current share price seems an excellent opportunity to build a position in a renowned company - after all, you would much rather buy closer to the low than the high, right?
TDOC’s Three-Month Price Performance
Let’s now take a close look at Teladoc, with an eye on where it stands after falling so much, along with what we can expect going forward.
About Teladoc
Teladoc — with a market cap of $1.3 billion — is a provider of virtual access to high-quality healthcare and expertise globally. Based in Purchase, NY, the company offers virtual medical services, including general medical, specialty medical, chronic condition management and mental health.
What’s Dragging Down TDOC Stock?
Growing competition in the virtual care space is bad for Teladoc’s pricing. The space also attracted the retail behemoth Amazon.com, which combined a virtual care clinic with One Medical, its virtual and in-person primary care organization.
The telehealth market is evolving rapidly. Although the COVID-19 pandemic initially drove a surge in demand for virtual care, this demand has shifted as restrictions eased. Experts believe that for telehealth to remain effective, it can adopt a hybrid model that integrates virtual care with traditional in-person healthcare providers. Coordinated care between these models will be essential to meet changing patient needs and ensure comprehensive healthcare delivery.
Rising expenses are hurting Teladoc, although a chunk of that is coming mostly from goodwill impairments. It has incurred significant losses in each period since its inception. As of June 30, 2024, the company had an accumulated deficit of $16.1 billion, which widened from $15.2 billion reported in 2023 end. These losses and accumulated deficits stemmed from substantial investments made by the company to acquire new clients, build its proprietary network of healthcare providers and develop its technology platform.
Annual EPS estimates for TDOC have been revised downward over the past 30 days, reflecting concerns about the company’s near-term profitability.
Teladoc had cash and cash equivalents of $1.2 billion as of June 30, 2024, which declined 3.4% from the figure in 2023-end. The company does not have earnings to service its debt obligation. Net cash provided by operating activities amounted to $97.6 million in the first half of 2024, which dropped 14.6% year over year.
Long-Term Prospects to Drive TDOC Stock
Despite the headwinds, Teladoc is well-positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
The company's efforts to expand its product offerings are a significant positive. Teladoc has enhanced its Primary360 service by broadening its capabilities. It also introduces new services to improve care coordination and provide in-home care options. These initiatives help drive membership growth. Given the rapid momentum seen with the Primary360 service, Teladoc is likely to introduce more products and solutions in the near future.
U.S. Integrated Care Members totaled 92.4 million as of June 30, 2024, which increased 8% from a year ago. TDOC expects the membership to grow to the 92.5-94 million range.
This June, it showcased data from two studies highlighting its predictive modeling capabilities in aiding members with type 2 diabetes to manage their blood sugar levels through its diabetes management program. Using machine learning, the company is expected to continue providing better care for its members, which will likely bring more people into its programs.
Leveraging AI allows the company to enhance digital interventions while maintaining a human touch in member interactions, resulting in better health outcomes. AI can also help the company streamline healthcare delivery and diversify the business, making it more efficient and scalable over the long term. This will allow Teladoc to reach more members with personalized guidance and support.
Beyond North America, the company operates in South America, Europe, Asia-Pacific and the Middle East. Its international business expansion will provide essential diversification benefits in the long term, especially as competition intensifies in the U.S. market. The company's extensive platform and global network offer a competitive advantage in growing its international business.
TDOC: A Value-Driven Choice?
Teladoc is trading at a discount compared to the industry average. It presents a compelling investment opportunity with its attractive forward 12-month price-to-sales ratio of 0.48X, lower than the industry average of 1.01X. The company has a Value Score of A.
In comparison, its peers like American Well Corporation AMWL and Phreesia, Inc. PHR are trading at 0.39X and 2.98X, respectively.
TDOC Stock Holds Promise
While Teladoc has strong long-term potential, the current market conditions and specific challenges facing the company cannot be ignored. Investors should note that rising expenses, investments to develop its technology platform and intense competition in the domestic market can keep its bottom line under pressure. But TDOC remains one of the best-positioned global virtual healthcarecompanies with favorable valuation to achieve sustainable membership growth.
Overall, the outlook is largely neutral for TDOC shares. It currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Investment Research
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.